<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/4D0DCB45-3ED8-494B-8C55-B5E8DF9DB522"><gtr:id>4D0DCB45-3ED8-494B-8C55-B5E8DF9DB522</gtr:id><gtr:name>UNLISTED</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Obstetrics and Gynaecology</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4D0DCB45-3ED8-494B-8C55-B5E8DF9DB522"><gtr:id>4D0DCB45-3ED8-494B-8C55-B5E8DF9DB522</gtr:id><gtr:name>UNLISTED</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/933058B8-E552-473D-B8DE-F16A53E359C9"><gtr:id>933058B8-E552-473D-B8DE-F16A53E359C9</gtr:id><gtr:firstName>Susan</gtr:firstName><gtr:surname>Ozanne</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/2D868DDA-54F2-4881-865C-CCE9D1496167"><gtr:id>2D868DDA-54F2-4881-865C-CCE9D1496167</gtr:id><gtr:firstName>Ionel</gtr:firstName><gtr:surname>Sandovici</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER_COI</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/234E976C-06EC-43A4-88CD-EFF4EDF6CB3A"><gtr:id>234E976C-06EC-43A4-88CD-EFF4EDF6CB3A</gtr:id><gtr:firstName>Miguel</gtr:firstName><gtr:surname>Constancia</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/521E032C-C065-41B2-9CEA-9A06C8BC5312"><gtr:id>521E032C-C065-41B2-9CEA-9A06C8BC5312</gtr:id><gtr:firstName>Antonio</gtr:firstName><gtr:surname>Vidal-Puig</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FH003312%2F1"><gtr:id>8ED79801-0C1B-4C0B-96CE-21370BEC0D41</gtr:id><gtr:title>Role of the imprinted Igf2 gene in pancreatic development and function</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/H003312/1</gtr:grantReference><gtr:abstractText>The pancreas is a large gland in the body with two very important functions: it makes insulin and digestive enzymes. The part of the pancreas which produces insulin and other hormones is called the endocrine pancreas. The part of the pancreas that produces the digestive enzymes is called the exocrine pancreas. Digestive enzymes break down food into small components allowing it to be easily absorbed from the intestine. Insulin is produced by specialized cells of the endocrine pancreas called beta cells. Insulin controls your sugar levels in the blood and makes sure that the body cells get enough energy and can store it for later use. The pancreas is able to 'sense' the level of sugar in the blood - if too high the beta cells make and secrete more insulin. If the level is too low, it secretes less. There are conditions when not only more insulin is needed but the number of beta cells needs to increase in order to cope with the increased demand for insulin. These circumstances include normal ageing, pregnancy and obesity to mention a few. Failure to increase the number of beta cells in the above conditions can lead to increased levels of sugar in the blood and diabetes. We know little about how the pancreas is able to increase the number of beta cells when needed. Consequently, to determine the factors that control this adaptive process is very important. The aim of this study is to determine precisely how a gene, that we think is a master regulator of pancreatic growth and function, actually works. This gene encodes for a protein that is similar to insulin - it is suggestively called insulin-like growth factor 2 (Igf2). We have preliminary evidence suggesting that Igf2 is an important factor that controls the normal development of the pancreas and makes beta cells multiply when needed. Many of our attempts to decipher mechanisms which are important for human health and disease both rely and benefit from studying animal models. In this study we will use mice because their pancreas is similar to the human one and because we can remove the Igf2 gene in their beta cells or in the entire pancreas, allowing us to understand how this gene works. We can also increase the amount of Igf2 produced by the beta cells or in the entire pancreas. We will study the development and the structure of the pancreas that can not make Igf2 or makes more Igf2 than normal mice. We will pay particular attention to the effect of the lack or excess of Igf2 on development of the pancreas and the number of beta cells during ageing. We will also study how changing the amount of Igf2 affects the way pancreas makes new beta cells during normal pregnancy, during exposure of mice to high-fat diet (to mimic human obesity) or when the pancreas is injured. We will use these experiments to find which other genes are under the control of Igf2. The results of this study will help to understand better how the pancreas develops, how it works during normal circumstances and how it adapts to conditions which increase the demand for insulin.</gtr:abstractText><gtr:technicalSummary>Physiological conditions such as normal ageing and pregnancy are associated with increased demands for insulin. These needs are also increased in conditions that associate excess nutrient intake such as obesity. In all these circumstances it is essential that the insulin-producing beta-cells can proliferate in response to the increased needs. Recent studies have shown that insulin/IGF signalling regulates beta-cell proliferation and that Insulin-like growth factor 2 (Igf2), a small ligand similar to proinsulin, acts as a mitogen and cell survival factor. However the precise role of Igf2 in pancreas development and function is unknown. This application addresses this deficit in knowledge. This will be achieved using our newly generated conditional Igf2 allele as well as existing mouse models, in combination with exposures that induce beta-cell proliferation (pregnancy, high-fat feeding, partial duct ligation). Our preliminary data suggests that conditional deletion of Igf2 in beta-cells leads to reduced beta-cell mass and that there were high levels of Igf2 expression in the expanded islets of the obese ob/ob mice, suggesting an active role of Igf2 in beta-cell proliferation in response to high metabolic demand. The facultative pancreatic endocrine progenitor cells recently identified in an injury model also express high levels of Igf2 suggesting an involvement of Igf2 in controlling beta-cell neogenesis. The current proposal will capitalise on these findings and will address the following specific questions: Which are the pathways controlled by Igf2 in regulating beta-cell mass during development and in conditions associated with high metabolic demand? Is Igf2 the long-sought and elusive promoter factor of acinar growth during development? Does Igf2 have a regulatory role in beta-cell neogenesis? Answering these questions will lead to new insights into fundamental processes relevant for human physiology and disease.</gtr:technicalSummary><gtr:fund><gtr:end>2012-09-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2009-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>408011</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Sir William Dunn School of Pathology</gtr:department><gtr:description>Igf2 in cell proliferation/growth</gtr:description><gtr:id>FE1E6D04-A49B-4E97-A399-40F2005EBD53</gtr:id><gtr:impact>One publication so far in Embo Molecular Medicine</gtr:impact><gtr:partnerContribution>Analysis of mouse mutations</gtr:partnerContribution><gtr:piContribution>Biological materials, including mouse models, with manipulations of Igf2 and intronic Igf2 microRNA-483
Intellectual input in experimental design</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Physiology, Development and Neuroscience</gtr:department><gtr:description>Igf2 in neurogenesis</gtr:description><gtr:id>8748FD95-E342-43E3-B14D-0238127B808E</gtr:id><gtr:impact>Publication in Nature Communications</gtr:impact><gtr:partnerContribution>Conducted experimentation on Igf2 conditional knock-outs</gtr:partnerContribution><gtr:piContribution>Provided biological materials (e.g. Igf2 conditional mouse model) and intelectual input on experimental design</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Southern California</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Igf2 in cardiac function</gtr:description><gtr:id>0C9651F3-18E5-4F58-8EE9-242DF805E911</gtr:id><gtr:impact>One publication so far (in Circulation Research)</gtr:impact><gtr:partnerContribution>Analysis of a cardiac-specific Igf2 knockout
Advise on planned projects looking at relationship between placenta and cardiac function using IGF related mouse models</gtr:partnerContribution><gtr:piContribution>Generation of conditional mouse model for Igf2</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We discovered that the Igf2 gene is very important for the growth of the pancreas in fetal and early postnatal life. We developed mice that don't have Igf2 in the different cell types that make up the pancreas. Unexpectedly we found that the most of the Igf2 produced in the pancreas comes from the mesenchyme (or connective tissue). The mesenchyme thus acts as a reservoir of this important growth factor that then acts on other cell types. Accordingly, we found that when Igf2 is not produced by the mesenchyme the whole pancreas is smaller, including the cell types that generate enzymes for food digestion and those cells specialised in making insulin.</gtr:description><gtr:exploitationPathways>We identified a major mesenchymal factor that is important for pancreatic growth and function. This may have important clinical implications, from cancer to diabetes research.</gtr:exploitationPathways><gtr:id>680DA178-4B0F-4CFE-91B5-242DAA5D64A0</gtr:id><gtr:sectors><gtr:sector>Education,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/82B44D6D-1D47-420F-A83A-7FBE4F7F610F"><gtr:id>82B44D6D-1D47-420F-A83A-7FBE4F7F610F</gtr:id><gtr:title>Raised late pregnancy glucose concentrations in mice carrying pups with targeted disruption of H19delta13.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/de5cc56cdcf28b374535ff101a94c3fb"><gtr:id>de5cc56cdcf28b374535ff101a94c3fb</gtr:id><gtr:otherNames>Petry CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EABA4CB1-4BAE-4E80-8CBD-B17D3AE642FF"><gtr:id>EABA4CB1-4BAE-4E80-8CBD-B17D3AE642FF</gtr:id><gtr:title>Increased placental glucose transport rates in pregnant mice carrying fetuses with targeted disruption of their placental-specific Igf2 transcripts are not associated with raised circulating glucose concentrations.</gtr:title><gtr:parentPublicationTitle>Experimental diabetes research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/de5cc56cdcf28b374535ff101a94c3fb"><gtr:id>de5cc56cdcf28b374535ff101a94c3fb</gtr:id><gtr:otherNames>Petry CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1687-5214</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/92B5FAFB-424F-4DDF-978D-24D9F3C32225"><gtr:id>92B5FAFB-424F-4DDF-978D-24D9F3C32225</gtr:id><gtr:title>Developmental and environmental epigenetic programming of the endocrine pancreas: consequences for type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>Cellular and molecular life sciences : CMLS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/667db00f6cf95aef48f82282d543c8de"><gtr:id>667db00f6cf95aef48f82282d543c8de</gtr:id><gtr:otherNames>Sandovici I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1420-682X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/79D2373F-A609-4435-9AE5-91451095F6E0"><gtr:id>79D2373F-A609-4435-9AE5-91451095F6E0</gtr:id><gtr:title>How genome-wide approaches can be used to unravel the remaining secrets of the imprintome.</gtr:title><gtr:parentPublicationTitle>Briefings in functional genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/733850fdf7fb82ee6a55132bc1fc861b"><gtr:id>733850fdf7fb82ee6a55132bc1fc861b</gtr:id><gtr:otherNames>Cooper WN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>2041-2649</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B83E6649-9645-4B23-9648-1114B3D22B01"><gtr:id>B83E6649-9645-4B23-9648-1114B3D22B01</gtr:id><gtr:title>Ageing is associated with molecular signatures of inflammation and type 2 diabetes in rat pancreatic islets.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/667db00f6cf95aef48f82282d543c8de"><gtr:id>667db00f6cf95aef48f82282d543c8de</gtr:id><gtr:otherNames>Sandovici I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E7104D7D-215B-41B5-B263-3AED462DEEE6"><gtr:id>E7104D7D-215B-41B5-B263-3AED462DEEE6</gtr:id><gtr:title>Differential genomic imprinting regulates paracrine and autocrine roles of IGF2 in mouse adult neurogenesis.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/675004a085038485abca695742edd156"><gtr:id>675004a085038485abca695742edd156</gtr:id><gtr:otherNames>Ferr?n SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7845CF43-747D-4C2E-9C52-1EE74B1B1FE7"><gtr:id>7845CF43-747D-4C2E-9C52-1EE74B1B1FE7</gtr:id><gtr:title>Igf2 pathway dependency of the Trp53 developmental and tumour phenotypes.</gtr:title><gtr:parentPublicationTitle>EMBO molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1b4591791ebf0ee92bbc37bd779db063"><gtr:id>1b4591791ebf0ee92bbc37bd779db063</gtr:id><gtr:otherNames>Haley VL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1757-4676</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/H003312/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>